Nicotinell 2 mg Norvegia - norvegiană - Statens legemiddelverk

nicotinell 2 mg

haleon denmark aps - nikotinpolakrilin - medisinsk tyggegummi med tropisk fruktsmak - 2 mg

Nicotinell 4 mg Norvegia - norvegiană - Statens legemiddelverk

nicotinell 4 mg

haleon denmark aps - nikotinpolakrilin - medisinsk tyggegummi med tropisk fruktsmak - 4 mg

Pascoflair - Norvegia - norvegiană - Statens legemiddelverk

pascoflair -

pascoe pharmazeutische präparate gmbh - pasjonsblomst - tablett, drasjert - 425 mg

Panacur vet 40 mg/ g Norvegia - norvegiană - Statens legemiddelverk

panacur vet 40 mg/ g

intervet international b.v. - fenbendazol - pulver - 40 mg/ g

Panodil 500 mg Norvegia - norvegiană - Statens legemiddelverk

panodil 500 mg

haleon denmark aps - paracetamol - tablett, filmdrasjert - 500 mg

Pepcid 10 mg Norvegia - norvegiană - Statens legemiddelverk

pepcid 10 mg

mcneil sweden ab - famotidin - tablett, filmdrasjert - 10 mg

Vosevi Uniunea Europeană - norvegiană - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitt c, kronisk - antivirale midler til systemisk bruk - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (se kapittel 4. 2, 4. 4 og 5.

Sulfa-Streptocillin vet 250 mg / 500 mg / 4 g Norvegia - norvegiană - Statens legemiddelverk

sulfa-streptocillin vet 250 mg / 500 mg / 4 g

boehringer ingelheim animal health nordics - benzylpenicillinprokain / dihydrostreptomycinsulfat / sulfadimidin - uteritorie, tablett - 250 mg / 500 mg / 4 g

Vanquin 50 mg Norvegia - norvegiană - Statens legemiddelverk

vanquin 50 mg

viatris as - pyrviniumembonat - tablett, drasjert - 50 mg

Calquence Uniunea Europeană - norvegiană - EMA (European Medicines Agency)

calquence

astrazeneca ab - acalabrutinib - leukemi, lymfocytisk, kronisk, b-celle - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.